Mail & Guardian
Mail & Guardian
501y v2latest news & developments
(John McCann/M&G)

‘Don’t panic’ about India Covid variant

Scientists in South Africa say there’s no evidence that the B.1.617 is worse than our local variant

Covid-19 variant may protect people against reinfection and other variants, research shows

The 501Y.V2 strain produces strong antibodies, but it’s not known how long immunity lasts, so being vaccinated remains essential

President urges caution against more contagious Covid variant as SA moves to level 1

The curfew is shorter, alcohol sale times almost normal and more people can meet at religious, social, political and cultural gatherings

South Africa is offering its AstraZeneca vaccines to fellow African countries: Mkhize

Reselling the jabs will prevent money being wasted on a vaccine that is not particularly efficacious on the variant that is dominant in South Africa

16 sites on 17 February: Eight things you should know about SA’s J&J vaccine roll-out

Eighty thousand Johnson & Johnson jabs will arrive in South Africa on Tuesday and be taken to 16 sites where healthcare workers will be vaccinated

No silver bullet for Covid-19, but rather a cocktail

It is no good waiting for a vaccine or ivermectin or other miracle cures, we just need to do what we can do now

Can you get reinfected with Covid-19? SA has ‘4 000 potential reinfections’

Although the new strain 501Y.V2 of the virus has spread 50% more rapidly, current evidence shows that it is not more severe than the one experienced in the first wave